Highlights of Brain Tumor and CNS Research at ASCO With Morana Vojnic, MD, MBA

At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor Editorial Board member Dr. Morana Vojnic, Assistant Professor of Medicine at Hofstra/Northwell Health, sat down to share the most significant updates in brain tumor and central nervous system (CNS) tumor research being presented at the meeting, including:

  • The phase 3 GBM AGILE trial investigating VAL-083 in newly diagnosed and recurrent glioblastoma
  • Updates in targeted therapies for recurrent glioblastoma
  • Trials investigating chimeric antigen receptor (CAR) T-cell therapy for CNS lymphoma
  • Data on tumor-treating fields (TTF) plus stereotactic radiosurgery (SRS) for glioblastoma
  • And more!

In addition, Dr. Vojnic shares closing thoughts for Brain Tumor Awareness Month in May and messages of hope for patients living with brain tumors.

About Dr. Vojnic

Morana Vojnic, MD, MBA, is an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health and a Medical Oncologist at Lenox Hill Hospital, where she serves as Director of Oncologic Services in the Brain and Spine Metastases Program. She specializes in thoracic and neuro-oncology, with expertise in the treatment of lung cancer, mediastinal tumors, head and neck cancer, brain cancer, and metastatic lesions of the brain and spine. With a background in molecular genetics, Dr. Vojnic designs personalized treatment plans and protocols using targeted drugs, immunotherapy, and chemotherapy for the treatment of patients with these diseases.

Related Articles

Responses

Your email address will not be published. Required fields are marked *